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Summary 
We have recently demonstrated that tumor necrosis factor ol (TNF-ot) potentiates interleukin 
3  (IL-3)- and granulocyte/macrophage colony-stimulating factor-induced growth of CD34 + 
hematopoietic progenitor cells (HPC), and favors the generation of dendritic/Langerhans cells. 
The stimulatory effect of TNF-ot was detailed in the present study. Thus, CD34 + HPC entering 
in cycle (S/G2M)  after a 48-h pulse with IL-3 expressed the transferrin receptor (TfR),  and 
fluorescence-activated  cell sorter-separated TfR + HPC, but not TIP,- HPC, showed a high pro- 
liferative response to IL-3. In contrast, TfR- HPC were found to undergo strong proliferation 
in response to IL-3  +  TNF-cz. Limiting dilution experiments indicated that TNF-cz increased 
both the frequency and the average size of clones generated from TfR- HPC as a result of the 
development of a higher number of large clones. In contrast, TNF-ot did not enhance the IL-3- 
dependent  proliferation  of TfR +  HPC.  Preculturing  CD34 +  HPC  for 48  h  with  TNF-ot 
enhanced the subsequent generation of IL-3-dependent colony-forming units. Precultures with 
TNF-a or cultures with suboptimal doses of TNF-cz allowed the recruitment of cells with both 
granulocytic and monocytic differentiation potential. Taken together, our results indicate that 
TNF-ot recruits a subpopulation of CD34 § HPC hyposensitive to IL-3, with high proliferative 
capacity and some features of multipotential progenitors, that are likely to be more primitive 
than those responding to IL-3 alone. 
M 
odels  of in  vitro  hematopoiesis  have  revealed  that 
regulation of development of human hematopoietic 
progenitor  cells  (HPC)  depends  upon  so-called  "growth 
stimulator),  molecules"  such  as  IL-3,  GM-CSF,  G-CSF, 
M-CSF, and stem cell factor, and so-called "growth inhibi- 
tory molecules" such as IFN, TGF-/3, and TNF (1, 2). How- 
ever, recent studies have shown that this concept of positive 
and negative regulators of myelopoiesis needs to be modu- 
lated. For instance, IFN-3' has recently been described to poten- 
tiate IL-3 and GM-CSF development of normal HPC (3, 4). 
Also, TGF-/~ has been shown to enhance the effects of GM- 
CSF on murine neutrophil (5) and macrophage (6) develop- 
ment. Moreover, we and others have demonstrated that TNF-ot 
and -/$ stimulate IL-3- and GM-CSF-dependent proliferation 
of normal human CD34 + HPC (7, 8) and murine early pro- 
genitors (2). 
We have recently described that the potentiating effect of 
TNF-ot on early myelopoiesis was followed by an induction 
of the generation of dendritic/Langerhans cells (9)  and an 
inhibition of erythroid and granulopoietic development (10). 
The present study was designed to further elucidate the mech- 
anisms of the stimulatory effects of TNF-ot on early myelopoi- 
esis. It is shown that TNF-ot potentiates early myelopoiesis 
through the recruitment of  a population of  cells hyporesponsive 
to IL-3 alone. The recruited progenitors display a high prolifer- 
ative potential and likely represent a population more primi- 
tive than that responding to IL-3. 
Materials and Methods 
Collection and Purification of Cord Blood HPC.  Umbilical cord 
blood samples were obtained according to institutional guidelines. 
Cells bearing  CD34  antigen  were  isolated from nonadherent 
mononuclear fractions through positive selection by indirect im- 
mune "panning" using anti-My10 mAb (HPCA-1; Becton Dick- 
inson & Co., Mountain View, CA), as reported elsewhere (11). A 
second purification step was performed using a cocktail of mAbs 
and magnetic beads (Dynabeads M450; Dynal, Oslo, Norway), as 
described (7). Thus,  in  all experiments the isolated cells were 
95-99%  CD34 +. 
Cell Cultures in Liquid Medium.  CeUs  were precultured for 48 h 
either with  10 ng/ml IL-3 (sp act,  5  x  106 U/rag;  Schering- 
Plough Research Institute, Kenilworth, NJ) before FACS  |  sorting 
(Becton Dickinson & Co.) according to transferrin receptor (TfK) 
expression, or with 25 ng/ml TNF-ct (sp act, 2  x  107 U/rag; 
Genzyme  Corp., Cambridge, MA) for preincubation experiments. 
The medium consisted of RPMI 1640 (Gibco Laboratories, Grand 
Island, NY) supplemented  with 10% (vol/vol) heat-inactivated  FCS 
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5  x  10-s M  2-ME,  100 U/ml penicillin,  and  100/~g/ml strep- 
tomycin (referred to as complete medium). For initiation of clono- 
genie assays after preincubation with cytokines, cells were washed 
four times, further incubated for 3 h (37~  in complete medium, 
and washed again to eliminate the pulsing cytokine. 
Progenitor Assays in Semisolid Medium.  Semisolid cultures of 1 
ml  were  performed in  methylceUulose by plating  103  cells  per 
tissue  culture-grade  35-mm petri dish  (Coming  Glass Works, 
Coming,  NY),  without erythropoietin (Epo), as previously de- 
scribed in detail (11). Duplicate dishes were plated in each experi- 
ment, and after 7 and 14 d (37~  5% COz), colonies (>t50 cells) 
were counted using phase-contrast microscopy. 
Limiting Dilution Studies.  Limiting dilution was performed at 
one cell per well in 96-well round-bottomed microtest tissue cul- 
ture plates (Nunc, Roskilde, Denmark), as previously described (7), 
in IMDM containing 30%  FCS,  10 -~ M  2-ME, 0.5%  (wt/vol) 
BSA, and L-glutamine and antibiotics  as indicated above. Each factor 
was tested in 540-2,000 wells. After 6 d of culture, positive wells 
were scored and the number of cells in each clone was determined. 
Clone frequency was determined as the log of the fraction of non- 
responding wells, and average clone size was calculated as: the ratio 
of total cell number enumerated in the wells seeded/number of 
responding cells present in the wells observed. In some experiments, 
cultures were prolonged until day 20 and cells from individual clones 
ranging from 2,000 to 8,000 cells were processed for double-color 
fluorescence analysis  (CD14 and CD15).  The frequency of such 
clones was between 2 and 4% of total cells, and thus the proba- 
bility that observed clones may derive from more than one cell was 
not significant. 
Flow  Cytometry Anal2/sis and  Cell  Sorting.  For  cell  surface 
phenotyping, double-color fluorescence was performed according 
to  standard  direct immunofluorescence techniques  using  FITC- 
conjugated anti-Leu-M1 (CD15) and PE-conjugated anti-Leu-M3 
(CD14) (Becton Dickinson & Co.). Negative controls were per- 
formed with unrelated murine mAbs. Fluorescence analysis was 
determined with a FACScan |  (Becton Dickinson &  Co.). 
For cell cycle analysis, cells were incubated for 48-72 h in the 
presence of 10 ng/ml lb3, and 0.1 ~g/ml colcemid (Gibco Labora- 
tories) was added during the last 16 h.  Cells were subsequently 
processed for membrane fluorescence  and permeabilized (15 rain) 
in 70% methanol. After washes, cells were incubated  15 rain at 
37~  with 2,000 U/ml ribonuclease A (sp act, 4,000 U/mg; Wor- 
thington Biochem. Corp., Freehold, NJ). 2/~g/ml propidium io- 
dide (Sigma Chemical Co., St. Louis, MO) was added and cell sur- 
face  Ag  expression  and  DNA  content  were  analyzed  with  a 
FACScan | 
For cell sorting, after 48 h of preincubation in II.,3 (10 ng/ml), 
cells were collected, washed several times, and labeled with FITC- 
conjugated anti-TfIL (CD71) (Becton Dickinson & Co.). Using a 
FACStar Plus |  (Becton Dickinson & Co.), the cells were separated 
according to TfR expression into  a TilL-  fraction and a TfR + 
fraction.  Reanalysis of the  sorted  populations  showed a  purity 
>97%. 
Results 
TNF-~  Recruits  a  Subset  of  CD34 +  HPC  with  High 
Proliferative Capacity, but Hyporesponsiveness to IL-3 Alone.  We 
have previously shown that TNF-c~ stimulates early myelopoi- 
esis through an enhancement of both the frequency and done 
size  of the  responding  CD34 +  HPC  (7).  Here  we  ques- 
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Figure  1.  Expression of TfR on CD34 + HPC in S/G2M after culture 
with I1,3. CD34 + HPC cultured for 48 h in medium alone (A and B) 
or in the presence of 10 ng/ml Ib-3 (C and D) were labded with FITC 
anti-TfR (B and/9) or a FITC control antibody (A and C) and stained 
with propidium iodide. Fluorescence was analyzed with a FACScan  | 
tioned whether the enhanced clone size was due to the specific 
recruitment  of an IL-3-unresponsive population with high 
proliferative potential, or, alternatively, to an effect of TNF-a 
on the  growth  rate of IL-3-sensitive cells.  Thus,  we sepa- 
rated CD34 + HPC  according  to their growth  response to 
IL-3. Double-color fluorescence analysis showed that cells trig- 
Table  1.  CD34+TfR -  Cells Generate Day 7 CFU in Response 
to IL-3  +  TNF-cr 
No.  of day 7 colonies 
TfR §  TfR- 
IL-3  +  IL-3  + 
Exp.  IL-3  TNF-a  IL-3  TNF-a 
1  37  36  16  70 
36  35  17  75 
2  45  40  12  100 
55  32  11  109 
3  38  35  13  82 
40  33  10  92 
CD34 + HPC were FACS|  according to TfR expression after a 
48-h preincubation in IL-3 (10 ng/ml) and assessed for their ctonogenic 
capacity. Duplicate dishes, plated with 103 cells in presence of IL-3 (10 
ng/ml) or IL-3 + TNF-ol (25 ng/ml), were scored for numbers of colo- 
nies on day 7 (colonies 950 cells). Values are from three unrelated ex- 
periments. 
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(Fig. 1 D), whereas cells cultured in medium alone express 
only low levels of TfK and remain in the G1 phase (Fig.  1 
B). After a 48-h culture with IL-3, the TfR § population 
(65-75% of total cells; range of six experiments) contained 
mostly cells in S-G2M whereas the TfR- cells were mostly 
in  G0-G1  (Fig.  1 D).  As  shown in Table  1,  TfR §  cells 
generated two to five times more CFU than TfR-  cells in 
response to IL-3 alone. However, while TNF-ol did not alter 
IL-3-induced development of CFU from TfR + cells, it en- 
hanced four- to eightfold the IL-3-dependent generation of 
CFU from TfR- cells (ranges from three unrelated experi- 
ments). Thus, in response to IL-3  +  TNF-a,  TfR-  cells 
yielded approximately twice as many colonies as did TfR + 
cells.  Limiting dilution experiments showed that,  while 
TNF-t~ did not affect IL-3-dependent generation of clones 
from TfP-.  + cells, it enhanced 2.5-3 times the frequency of 
responding clones from TfR- cells (range from three inde- 
pendent experiments, one of which is shown in Fig. 2). Fur- 
thermore, TNF-a did not alter the size distribution of dones 
generated from TfR + cells. In contrast, TNF-u essentially 
stimulated the generation of large dones from TfR-  cells 
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Figure  2.  TNF-(x  recruits a population of cells with high proliferative 
capacity. After 48 h of preincubation in Ib3, and subsequent FACSr 
according to TfR expression, CD34 + HPC were cultured at one cell/well 
in the presence of IL-3 (10 ng/ml) or Ib3 + TNF-oL (25 ng/ml). 540 wells 
were seeded for each culture condition. After 7 d of culture,  done size 
was determined, by numeration, using an inverted  microscope coupled 
to an image analyzer. TNF-ot or medium alone did not induce the devel- 
opment of any clones. The clones were classified according to number of 
ceils per clone. Numbers plotted correspond  to the mean of triplicates of 
180 wells observed.  Clone frequency and average clone size were deter- 
mined as described in Material and Methods.  (TJR §  Clone frequencies 
were 36.0% for IL-3 and 38,7% for II,-3 +  TNF-t~;  average clone sizes 
(ceils/done) were 102 for I1:3 and 94 for 11:3 +  TNF-~t.  (TJR-) Clone 
frequencies were 13.6%  for II:3 and 44.8% for 11:3 +  TNF-a; average 
clone sizes (ceils/clone) were 84 for I1:3 and 148 for [1:3  +  TNF-~. Data 
are from one experiment representative  of three. 
as observed by an average clone size increasing from 69  -+ 
13 cells/clone in 1I,-3 to 138 +_ 10 cells/clone in IL-3 + TNF-c~ 
(means of three unrelated experiments, one of which is shown 
in Fig.  2).  Taken together, these results demonstrate that 
TNF-ce allows the recruitment of cells hyporesponsive to IL-3 
alone that display a high proliferative  potential. 
A  TNF-cr Pulse Is Su~cient to Enkance tke Proliferative Re- 
sponse to IL-3.  As the potentiating effect of TNF-ot reflects 
the recruitment of an IL-3-hyporesponsive population, we 
wondered whether the presence of TNF-oL would be required 
during the whole course of proliferation or at the initiation 
of the process. Thus, CD34 + HPC were precultured in the 
presence of TNF-a or medium alone, and, after extensive 
washes, tested for their proliferative response to IL-3, as de- 
termined by  [3H]TdR uptake and enumeration of day  7 
CFU. Kinetics experiments, performed by [3H]TdR uptake, 
indicated that a 48-h pulse in TNF-ol was suiScient to allow 
subsequent levels of IL-3-dependent proliferation identical to 
those obtained when cells were continuously cultured with 
IL-3 +TNF-~ (not shown). This enhanced DNA replication 
was confirmed by enumeration of day 7 colonies. As shown 
in Fig. 3 A, cells pulsed with TNF-ot and subsequently cul- 
tured in IL-3 generated virtually as many day 7 CFU as cells 
incubated in IL-3 +TNF-o~ during the whole culture period. 
In addition, only TfR- cells were sensitive to the enhancing 
effect ofTNF-ct preincubation (not shown). Taken together, 
these results demonstrate that, to permit recruitment of the 
IL-3-hyporesponsive population, TNF-cg is required only at 
the initiation of the proliferative  process. 
TNF-~ Recruits a Population of Cells with Both Monocytic 
and Granulocytic Differentiation Potential.  We have recently 
shown that early potentiation of myelopoiesis by TNF-o~ is 
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Upregulation of 11:3 responsiveness after TNF-c~ preincuba-  Figure  3. 
tion reflects the recruitment  of a higher number of granulocytic and mono- 
cytic progenitors.  CD34 + HPC  were preincubated  for 48  h  in either 
TNF-Qt (25 ng/ml) or medium alone, washed, and seeded (103 cells/plate) 
in duplicate dishes in the presence of IL-3 (10 ng/ml) or I1:3  +  TNF-~ 
(25 ng/ml). Colonies ~50 cells were counted after 7 and 14 d. Data repre- 
sent the mean of five separate experiments  and are expressed as follows: 
100 x  (number of CFU/control number of CFU in IL-3 after preincuba- 
tion in medium)  -  100. 
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Figure  4.  Expression of CD14  and  CD15  on  clones  derived from 
CD34 + HPC. CD34 + HPC were seeded at one cell per well in presence 
oflb3 with or without suboptimal concentration of TNF-c~ (1.25 ng/ml). 
After 20 d of culture, large clones (2,000-8,000 cells/well) were selected 
and analyzed by double-color fluorescence for expression ofCD14 (mono- 
cytic cells) and CD15 (granulocytic cells). (A) Example of CD14-/CD15- 
clone  (undetermined  CFU);  (B)  example  of  CD14+/CD15 -  clone 
(CFU-M); (C) example of CD14-/CD15 + clone (CFU-G); (D) example 
of CD14 +/CD15 + clone (CFU-GM). 
followed by an inhibition of the development of granulopoietic 
cells (10), a phenomenon that interferes with the character- 
ization of the progenitors initially recruited. Thus, we studied 
whether pulsing cells with TNF-c~ for 48 h would prevent 
this late inhibition of granulopoiesis. As described above, IL- 
3-dependent generation of day 7 colonies  was equally enhanced 
by a 48-h pulse or a 7-d TNF-ol coculture (Fig. 3 A). How- 
ever, when CD34 + HPC were plated for 14 d, the IL-3 re- 
sponse differed strikingly between cells cultured with TNF-c~ 
for 14 d and those pulsed with TNF-c~ for only 48 h. Thus, 
preincubation in TNF-o~ enhanced total CFU numbers by 
41%  (Fig. 3 B) as a consequence of a 30 and 48% increase 
of CFU-G (Fig. 3 C) and CFU-M (Fig. 3 D), respectively. 
In contrast, the continuous presence of TNF-ol resulted in 
a 23% inhibition of total CFU numbers (Fig. 3 B), mostly 
as a result of a 46% inhibition of the CFU-G numbers (Fig. 
3 C) (10). 
Interestingly, a low concentration of TNF-o~ (1.25 ng/ml) 
was able to provide virtually all the potentiating effect of 
TNF-c~ observed after 7 d of culture, without demonstrating 
inhibitory effects  on day 14 CFU-G and CFU-M (not shown). 
This lack of inhibitory effects  of low concentrations of  TNF-ol 
allowed us to study the effects  of TNF-ot on CFU-GM gener- 
ation. Thus, CD34 + HPC were seeded at one cell per well 
in the presence of IL-3 with or without 1.25 ng/ml TNF-c~, 
and after 20 d of culture large clones (2,000-8,000 cells/clone) 
were selected and analyzed by double-color fluorescence for 
expression of CD14 (monocytic cells) and CD15 (granulo- 
cytic cells). Fig. 4 shows FACS  |  profile examples of clones 
lacking both CD14 + and CD15 + cells (undefined CFU; Fig. 
4 A); clones containing only CD14 + cells (CFU-M; Fig. 4 
B); clones containing only CD15 + cells (CFU-G; Fig. 4 C); 
and clones containing CD14 + as well as CD15 + cells (CFU- 
GM;  Fig. 4 D). 
Table 2 shows the mean of results obtained from three sep- 
arate single-cell experiments.  Thus, addition of TNF-ol to 
cultures did not modify the frequency of undetermined CFU 
(12.0 vs.  15.4%)  nor that of CFU-M (10.0 vs.  12.1%). In 
contrast,  addition of TNF-o~ to IL-3 cultures resulted in an 
increased frequency of CFU-GM clones from 9.4 to 47.5%. 
As a consequence, the proportion of CFU-G decreased from 
61.6 to 30.6%. 
These results demonstrate that TNF-c~ allows the recruit- 
ment of a population of CD34 + HPC with high prolifera- 
tive capacity, and  with both granulocytic and monocytic 
differentiation  potential. 
Discussion 
Previous studies by us and others have shown that TNF-o~ 
potentiates  the early proliferative response of CD34 + HPC 
to IL-3 and GM-CSF (7, 8, 12), and stimulates the genera- 
tion of dendritic Langerhans cells (9, 13). Yet, in line with 
previous reports  (14-17), we also demonstrated that, after 
this phase of potentiation, TNF-o~ inhibits  erythroid and 
Table  2.  TNF-ot Recruits a Population of Ceils with Both Monocytic and Granulacytic Differentiation Potential 
CD14-CD15-  clones 
(undetermined CFU) 
CD14-CD15 §  clones 
(CFU-G) 
CD14+CD15 -  clones 
(CFU-M) 
CD14§  + clones 
(CFU-GM) 
IL-3  15.4  (11.5-22.3)  61.6  (54.5-75.0)  12.1  (10.0-15.3)  9.4  (2.5-13.7) 
IL-3  +  TNF-(x  12.0  (6.7-21.0)  30.6  (27.9-34.2)  10.0  (6.8-12.5)  47.5  (32.3-55.6) 
CD34 + HPC were seeded at one cell per well (2,000  wells seeded per each culture condition) in the presence of IL-3 (10 ng/ml) with or without 
low concentration of TNF-o~ (1.25 ng/ml). After 20 d of culture, large clones (2,000-8,000 cells/clone) were selected and analyzed by double-color 
fluorescence  for expression of CD14 (monocytic cells) and CD15 (granulocytic cells). Data represent mean and range (in parentheses)  from three 
unrelated experiments and are expressed  as percentage of total analyzed clones  (40-50 per each culture condition for each experiment). 
1818  TNF-(~ Cooperates with Ib3 to Recruit Primitive CD34 + Progenitors granulocytic development (10). Here, we show, based on three 
observations, that the enhancing effect of TNF-ot on early 
myelopoiesis is due to the recruitment of primitive hemato- 
poietic progenitor cells  hyporesponsive to  IL-3.  First,  by 
separating  IL-3-sensitive  and  IL-3-hyposensitive  CD34 + 
HPC according to TfR expression, TNF-ot was found to allow 
specifically the recruitment of TfK- cells, which proliferate 
weakly in response to IL-3 alone. Second, preincubation ex- 
periments indicated that TNF-ot is required only during the 
initiation of the proliferative process, thus demonstrating that 
TNF-ot prepares cells to respond to IL-3. Third, morpho- 
logic and phenotypic characterization of clones generated in 
the presence of noninhibitory concentrations of TNF-c~ re- 
vealed that high proliferative potential cells selectively recruited 
by TNF-ot are in fact granulocyte/monocyte bipotent pro- 
genitors. 
Our claim considering TNF-c~ as an enhancer (7, and this 
study), rather than an inhibitor of early myelopoiesis, is sub- 
stantiated by other recent reports (8, 12). In particular, TNF-ot 
has been shown to potentiate the development of early mu- 
rine progenitors with high proliferative potential that are de- 
pendent upon the combination of IL-1  +  IL-3 or IL-1  + 
GM-CSF. In contrast, more committed progenitors, respon- 
sive to either IL-3 or GM-CSF, were not affected by TNF-o~ 
(2). In this context, another study has recently demonstrated 
that IL-3 receptor-negative progenitors are more primitive 
than those expressing IL-3 receptors (18).  Finally,  these in 
vitro observations, which identify TNF-ot as an important 
molecule for the recruitment of early hematopoietic progen- 
itors are supported by the demonstration of the radioprotec- 
tive effect of TNF-ol in vivo (19). Taken together, the critical 
role of TNF-c~ in early hematopoiesis is in accordance with 
the concept that development of the earliest progenitor cells 
necessitates the association of several factors (20,  21). 
Elucidation of the molecular mechanisms through which 
TNF-c~ potentiates IL-3-dependent early myelopoiesis cer- 
tainly deserves attention. In this context, we have observed 
(Sato, N., C. Caux, T. Kitamura, Y. Watanabe, K. Arai, J. 
Banchereau, and A. Miyajima, manuscript submitted for pub- 
lication) that TNF-ot is able, on CD34 + HPC,  to upregu- 
late the expression of the/3 chain common to the IL-3/IL- 
5/GM-CSF receptor complexes (22).  This finding affords a 
relatively simple explanation for the induction by TNF-ot of 
an enhanced proliferative response of HPC to IL-3 and GM- 
CSF.  A  recent study has also shown that TNF-c~ can up- 
regulate the expression of IL-3 and GM-CSF receptors on 
murine progenitors (12). However, at variance with our studies 
showing a direct effect of TNF-ot on single cells, this con- 
current study argues for an indirect role of G-CSF,  which 
is produced by low density bone marrow cells in response 
to TNF-c~. These contrasting conclusions may derive from 
species (mouse vs. human) or culture condition differences. 
In conjunction with the known stimulatory effect of a single 
in vivo injection of TNF-c~ on hematopoiesis (23), in vitro 
studies advocate for considering therapeutic pulses of TNF-ot 
to boost early hematopoiesis. Together with GM-CSF or 1L-3, 
such a treatment may allow a more efficient recovery from 
therapy-induced aplasia. 
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